Intervention

ANAVEX2-73

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

OLE of Phase 2b/3 Study ANAVEX2-73-AD-004NCT04314934 · 2019-10-10

OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001NCT04575259 · 2019-10-10

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's DiseaseNCT02756858 · 2016-03-01

Common conditions

Alzheimer Disease1 Alzheimer's Disease1 Parkinson Disease Dementia1

Leading sponsors

Anavex Life Sciences Corp.3

Trial status mix

COMPLETED3

Phase mix

PHASE23

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.